Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 175 (3), 347-350
- https://doi.org/10.1016/0014-2999(90)90574-p
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine releaseEuropean Journal of Pharmacology, 1989
- Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neuronsEuropean Journal of Pharmacology, 1989
- Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron)European Journal of Pharmacology, 1989
- Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brainBritish Journal of Pharmacology, 1987
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- The pharmacology and function of 5-HT3receptorsTrends in Neurosciences, 1986
- Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine NeuronsScience, 1983
- Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neuronsJournal of Neuroscience, 1983